FIMI invests $60m in Kamada for controlling stake
Israeli Biopharmaceutical Company Kamada Ltd. (Nasdaq: KMDA; Level:KMDA) announced today that it has entered into a share purchase agreement with Israeli private equity firm FIMI Opportunity Funds (FIMI) to purchase $60…
